Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis With Hunner's Lesions

To evaluate the efficacy and safety of Neovasculgen in interstitial cystitis with Hunner's lesions to reduce cicatricial changes in the bladder caused by electrocoagulation and to prevent secondary bladder shrinkage with a decrease in its volume.

Participants needed: 180
Trial details
Phase: Phase 2, Phase 3Age: 18-65Biological sex: FemaleType: InterventionalSponsor: JSC NextGenUpdated: Mar 10, 2026Locations: 1
Eligibility criteria

Written informed consent prior to any study-related procedures. [+6]

Any condition that prevents intravesical administration of medications. [+14]

Status: Recruiting

The Study is Being Conducted to Find a New Treatment for Patients Suffering From Interstitial Cystitis Without Hunner's Lesions.

To evaluate the efficacy and safety of Neovasculgen in interstitial cystitis and the prevention of secondary bladder shrinkage with a decrease in its volume.

Participants needed: 180
Trial details
Phase: Phase 2, Phase 3Age: 18-65Biological sex: FemaleType: InterventionalSponsor: JSC NextGenUpdated: Feb 5, 2026Locations: 1
Eligibility criteria

Written informed consent prior to any study-related procedures. [+6]

Any condition that prevents intravesical administration of medications. [+14]

Status: Recruiting

The Prospective, Double-blind, Multicenter, Placebo-controlled, Randomized, Comparative Clinical Trial

The main objective of the study is to evaluate the efficacy and safety of Neovasculgen® in a course dose of 2.4 mg in combination with standard drug therapy in patients with unilateral neuroischemic form of diabetic foot syndrome.

Participants needed: 144
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: JSC NextGenUpdated: Feb 5, 2026Locations: 1
Eligibility criteria

Male and female patients aged 18 years and above inclusive (at the time of study... [+9]

Age under 18. [+22]